(Q37595119)

21 August 2017

1 reference

title

Proteasome inhibition during myocardial infarction (English)

1 reference

21 August 2017

main subject

myocardial infarction

1 reference

Xichun Yu

1

1 reference

21 August 2017

David C Kem

series ordinal

2

1 reference

21 August 2017

publication date

10 September 2009

1 reference

21 August 2017

published in

Cardiovascular Research

1 reference

21 August 2017

volume

85

1 reference

21 August 2017

issue

2

1 reference

21 August 2017

page(s)

312-320

1 reference

Diversity of degradation signals in the ubiquitin-proteasome system

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

The ubiquitin-proteasome system in cardiac physiology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Understanding proteasome assembly and regulation: importance to cardiovascular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Contrasting proteome biology and functional heterogeneity of the 20 S proteasome complexes in mammalian tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Mammalian proteasome subpopulations with distinct molecular compositions and proteolytic activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Age-dependent declines in proteasome activity in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Fundamentals of reperfusion injury for the clinical cardiologist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

CHIP, a cochaperone/ubiquitin ligase that regulates protein quality control, is required for maximal cardioprotection after myocardial infarction in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Differential regulation of cardiomyocyte survival and hypertrophy by MDM2, an E3 ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Unlocking the Mdm2-p53 loop: ubiquitin is the key.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Loss of muscle-specific RING-finger 3 predisposes the heart to cardiac rupture after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Ubiquitination and degradation of the anti-apoptotic protein ARC by MDM2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

p53 initiates apoptosis by transcriptionally targeting the antiapoptotic protein ARC

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Modulation of Murf-1 and MAFbx expression in the myocardium by physical exercise training.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function: essential role of the proteasome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

PKA rapidly enhances proteasome assembly and activity in in vivo canine hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Peroxynitrite alters the catalytic activity of rodent liver proteasome in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Comparative resistance of the 20S and 26S proteasome to oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Oxidative modification of proteasome: identification of an oxidation-sensitive subunit in 26 S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Cardioprotection with palm tocotrienol: antioxidant activity of tocotrienol is linked with its ability to stabilize proteasomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Proteasome mediates removal of proteins oxidized during myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Reperfusion-induced translocation of deltaPKC to cardiac mitochondria prevents pyruvate dehydrogenase reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Translocation of deltaPKC to mitochondria during cardiac reperfusion enhances superoxide anion production and induces loss in mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Protein kinase Cdelta activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving BAD and the mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Activation of protein kinase C triggers its ubiquitination and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

The bortezomib-induced mitochondrial damage is mediated by accumulation of active protein kinase C-delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

The roles of PKCdelta and epsilon isoenzymes in the regulation of myocardial ischaemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Oxidative injury induces selective rather than global inhibition of proteasomal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Enhanced ubiquitination of cytoskeletal proteins in pressure overloaded myocardium is accompanied by changes in specific E3 ligases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Acute severe cardiac failure in a myeloma patient due to proteasome inhibitor bortezomib

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Role of nuclear factor-kappa B activation in acute ischaemia-reperfusion injury in myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Inhibitory kappa B kinase-beta is a target for specific nuclear factor kappa B-mediated delayed cardioprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Proteasome inhibition attenuates infarct size and preserves cardiac function in a murine model of myocardial ischemia-reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Molecular restoration of beta-adrenergic receptor signaling improves contractile function of failing hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Pathophysiological roles of G-protein-coupled receptor kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Hypoxia/ischemia modulates G protein-coupled receptor kinase 2 and beta-arrestin-1 levels in the neonatal rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Down-regulation of GRK2 after oxygen and glucose deprivation in rat hippocampal slices: role of the PI3-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Beta-arrestin- and c-Src-dependent degradation of G-protein-coupled receptor kinase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

MAPK-dependent Degradation of G Protein-coupled Receptor Kinase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Mdm2 is involved in the ubiquitination and degradation of G-protein-coupled receptor kinase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Proteasome degradation of GRK2 during ischemia and ventricular tachyarrhythmias in a canine model of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Proteasome inhibition 1 h following ischemia protects GRK2 and prevents malignant ventricular tachyarrhythmias and SCD in a model of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Tumor necrosis factor alpha, rapid ventricular tachyarrhythmias, and infarct size in canine models of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Myocardial ischemia and ventricular fibrillation: pathophysiology and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Into the heart: the emerging role of the ubiquitin-proteasome system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Proteasomal proteolysis in anoxia-reoxygenation, preconditioning and postconditioning of isolated cardiomyocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

The apoptosis inhibitor ARC undergoes ubiquitin-proteasomal-mediated degradation in response to death stimuli: identification of a degradation-resistant mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

A proteasome inhibitor confers cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Inhibition of the ubiquitin-proteasome pathway induces differential heat-shock protein response in cardiomyocytes and renders early cardiac protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Eat your heart out: Role of autophagy in myocardial ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Protein quality control and degradation in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Multiple cardiac proteasome subtypes differ in their susceptibility to proteasome inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

Atrogin-1/MAFbx enhances simulated ischemia/reperfusion-induced apoptosis in cardiomyocytes through degradation of MAPK phosphatase-1 and sustained JNK activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

The ubiquitin-proteasome system: a novel target for anticancer and anti-inflammatory drug research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVP309

21 January 2018

Identifiers

DOI

10.1093/CVR/CVP309

1 reference

release_4oivr35eyvgjfmue6prntmyd2u

21 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4oivr35eyvgjfmue6prntmyd2u

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference